283 related articles for article (PubMed ID: 26573774)
1. Downregulation of Bmi-1 is associated with suppressed tumorigenesis and induced apoptosis in CD44⁺ nasopharyngeal carcinoma cancer stem-like cells.
Xu X; Liu Y; Su J; Li D; Hu J; Huang Q; Lu M; Liu X; Ren J; Chen W; Sun L
Oncol Rep; 2016 Feb; 35(2):923-31. PubMed ID: 26573774
[TBL] [Abstract][Full Text] [Related]
2. ShRNA targeting Bmi-1 sensitizes CD44⁺ nasopharyngeal cancer stem-like cells to radiotherapy.
Xu XH; Liu XY; Su J; Li DJ; Huang Q; Lu MQ; Yi F; Ren JH; Chen WH
Oncol Rep; 2014 Aug; 32(2):764-70. PubMed ID: 24927072
[TBL] [Abstract][Full Text] [Related]
3. [Effect of gene silencing of Bmi-1 on proliferation regulation of CD44+ nasopharyngeal carcinoma cancer stem-like cells].
Xu X; Liu Y; Li D; Su J; Hu J; Lu M; Yi F; Reng J; Chen W
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 May; 29(10):941-7. PubMed ID: 26596015
[TBL] [Abstract][Full Text] [Related]
4. Effect of shRNA-Mediated Gene Silencing of Bmi-1 Expression on Chemosensitivity of CD44+ Nasopharyngeal Carcinoma Cancer Stem-Like Cells.
Xu XH; Liu Y; Li DJ; Hu J; Su J; Huang Q; Lu MQ; Yi F; Bao D; Fu YZ
Technol Cancer Res Treat; 2016 Oct; 15(5):NP27-39. PubMed ID: 26294655
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem-like cell characteristics induced by EB virus-encoded LMP1 contribute to radioresistance in nasopharyngeal carcinoma by suppressing the p53-mediated apoptosis pathway.
Yang CF; Peng LX; Huang TJ; Yang GD; Chu QQ; Liang YY; Cao X; Xie P; Zheng LS; Huang HB; Cai MD; Huang JL; Liu RY; Zhu ZY; Qian CN; Huang BJ
Cancer Lett; 2014 Mar; 344(2):260-71. PubMed ID: 24262659
[TBL] [Abstract][Full Text] [Related]
6. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
[TBL] [Abstract][Full Text] [Related]
7. Nigericin selectively targets cancer stem cells in nasopharyngeal carcinoma.
Deng CC; Liang Y; Wu MS; Feng FT; Hu WR; Chen LZ; Feng QS; Bei JX; Zeng YX
Int J Biochem Cell Biol; 2013 Sep; 45(9):1997-2006. PubMed ID: 23831840
[TBL] [Abstract][Full Text] [Related]
8. CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.
Lun SW; Cheung ST; Cheung PF; To KF; Woo JK; Choy KW; Chow C; Cheung CC; Chung GT; Cheng AS; Ko CW; Tsao SW; Busson P; Ng MH; Lo KW
PLoS One; 2012; 7(12):e52426. PubMed ID: 23285037
[TBL] [Abstract][Full Text] [Related]
9. CD44 and CD24 coordinate the reprogramming of nasopharyngeal carcinoma cells towards a cancer stem cell phenotype through STAT3 activation.
Shen YA; Wang CY; Chuang HY; Hwang JJ; Chi WH; Shu CH; Ho CY; Li WY; Chen YJ
Oncotarget; 2016 Sep; 7(36):58351-58366. PubMed ID: 27521216
[TBL] [Abstract][Full Text] [Related]
10. [In vitro study of joint intervention of E-cad and Bmi-1 mediated by transcription activator-like effector nuclease in nasopharyngeal carcinoma].
Luo T; Yan A; Liu L; Jiang H; Feng C; Liu G; Liu F; Tang D; Zhou T
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Mar; 43(3):229-239. PubMed ID: 29701183
[TBL] [Abstract][Full Text] [Related]
11. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
12. Extracellular serglycin upregulates the CD44 receptor in an autocrine manner to maintain self-renewal in nasopharyngeal carcinoma cells by reciprocally activating the MAPK/β-catenin axis.
Chu Q; Huang H; Huang T; Cao L; Peng L; Shi S; Zheng L; Xu L; Zhang S; Huang J; Li X; Qian C; Huang B
Cell Death Dis; 2016 Nov; 7(11):e2456. PubMed ID: 27809309
[TBL] [Abstract][Full Text] [Related]
13. Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and is Associated with Metastasis and Prognosis in Pancreatic Cancer.
Li J; Wang Y; Ge J; Li W; Yin L; Zhao Z; Liu S; Qin H; Yang J; Wang L; Ni B; Liu Y; Wang H
Cell Physiol Biochem; 2018; 51(1):262-277. PubMed ID: 30453285
[TBL] [Abstract][Full Text] [Related]
14. CD44(+) cells have cancer stem cell-like properties in nasopharyngeal carcinoma.
Janisiewicz AM; Shin JH; Murillo-Sauca O; Kwok S; Le QT; Kong C; Kaplan MJ; Sunwoo JB
Int Forum Allergy Rhinol; 2012 Nov; 2(6):465-70. PubMed ID: 22887934
[TBL] [Abstract][Full Text] [Related]
15. Identification of cancer stem-like CD44+ cells in human nasopharyngeal carcinoma cell line.
Su J; Xu XH; Huang Q; Lu MQ; Li DJ; Xue F; Yi F; Ren JH; Wu YP
Arch Med Res; 2011 Jan; 42(1):15-21. PubMed ID: 21376257
[TBL] [Abstract][Full Text] [Related]
16. Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic target.
Xie P; Yang JP; Cao Y; Peng LX; Zheng LS; Sun R; Meng DF; Wang MY; Mei Y; Qiang YY; Cao L; Xiang YQ; Luo DH; Yun JP; Huang BJ; Jia LJ; Qian CN
Cell Death Dis; 2017 Jun; 8(6):e2834. PubMed ID: 28569775
[TBL] [Abstract][Full Text] [Related]
17. Bmi-1 promotes the invasion and migration of colon cancer stem cells through the downregulation of E-cadherin.
Zhang Z; Bu X; Chen H; Wang Q; Sha W
Int J Mol Med; 2016 Oct; 38(4):1199-207. PubMed ID: 27600678
[TBL] [Abstract][Full Text] [Related]
18. Snail-mediated cancer stem cell-like phenotype in human CNE2 nasopharyngeal carcinoma cell.
Peng S; Wu C; Sun W; Liu D; Luo M; Su B; Zhang L; Mei Q; Hu G
Head Neck; 2018 Mar; 40(3):485-497. PubMed ID: 29024225
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma.
Cheung CC; Lun SW; Chung GT; Chow C; Lo C; Choy KW; Lo KW
BMC Cancer; 2016 Jul; 16():495. PubMed ID: 27431799
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA HNF1A-AS is upregulated and promotes cell proliferation and metastasis in nasopharyngeal carcinoma.
Zhuang K; Wu Q; Jin CS; Yuan HJ; Cheng JZ
Cancer Biomark; 2016; 16(2):291-300. PubMed ID: 26756620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
